Isabelle Ah-Sing

Banque de la Réunion SA engages in the provision of commercial banking services. The firm offers savings account, financial management, credit card, loans, money transfer, and on-line banking. It also provides insurance and risk management services. The company was founded on July 4, 1853 and is headquartered in Saint-Denis, France.

Part of JPM Participation, Harmonie SARL is a French company conducting a phase 3b randomized open-label study of nirsevimab to prevent hospitalizations due to respiratory syncytial virus (RSV) in infants under 12 months. The private company is based in Muides sur Loire, France. The study includes newborn babies to babies 12 months old who are in, or are approaching, their first RSV season. The Harmonie study is a large European interventional clinical trial aiming to determine the efficacy and safety of a single intramuscular dose of nirsevimab for the prevention of hospitalizations due to RSV-related LRTD in infants under 12 months of age who are not eligible to receive palivizumab. Sanofi and academic investigators worked together to design and deliver Harmonie with digital solutions to minimize the burden on families, site staff, and health systems. The trial opened at nearly 250 sites, supported by national institute of health research infrastructure (UK), the Pedstart network, and Netstap e.v., and has recruited over 8000 infants.